| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 12/04/2008 | US20080300204 Alpha-Synuclein Antibodies and Methods Related Thereto |
| 12/04/2008 | US20080300203 Stable Quantitation and Detection of Immune Response Levels with Non-Zero Background Peptides |
| 12/04/2008 | US20080300190 Human proIslet Peptides are used either alone or in combination with other pharmaceuticals in the treatment of type 1 and type 2 diabetes and other pathologies related to aberrant glucose, carbohydrate, and/or lipid metabolism, insulin resistance, overweight, obesity, polycystic ovarian syndrome, eating |
| 12/04/2008 | US20080300188 hybrid Fc; useful as a carrier of biologically active molecules |
| 12/04/2008 | US20080300187 Mutated hoxb4 proteins with improved stability, and methods of use thereof |
| 12/04/2008 | US20080300170 Compositions and methods for diagnosis and treatment for type 2 diabetes |
| 12/04/2008 | US20080300167 Patched genes and uses related thereto |
| 12/04/2008 | US20080299678 Methods for characterizing glycosylation sites |
| 12/04/2008 | US20080299671 Hydrophobic Interaction Chromatography |
| 12/04/2008 | US20080299618 Single domain ligands, receptors comprising said ligands, methods for their production and use of said ligands and receptors |
| 12/04/2008 | US20080299615 Beta1,3-N-acetyl-D-galactosamine transferase protein, nucleic acid encoding the same and method of examining canceration using the same |
| 12/04/2008 | US20080299610 Human toll homologue |
| 12/04/2008 | US20080299584 Using lymphocytes expressing jun kinase as tools in detecting modulators for treatment of cell proliferative disorders |
| 12/04/2008 | US20080299554 Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof |
| 12/04/2008 | US20080299548 polynucleotide having a homology of 95% or more with the polynucleotide specifically expressed in a mouse embryonic stem (ES) cell; used for the detection of an ES cell, screening for a somatic cell nuclear reprogramming substance, screening for a ES cell maintaining substance |
| 12/04/2008 | US20080299547 Novel stra6 polypeptides |
| 12/04/2008 | US20080299153 B. anthracis prevention and treatment: mutant b. anthracis lacking luxs activity and furanone inhibition of growth, ai-2 quorum sensing, and toxin production |
| 12/04/2008 | US20080299142 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 12/04/2008 | US20080299139 Mammalian cytokines; related reagents and methods |
| 12/04/2008 | US20080299137 Fusion Proteins That Bind Effector Lymphocytes And Target Cells |
| 12/04/2008 | US20080299136 Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disorders |
| 12/04/2008 | US20080299134 Recombinant Anti-Interleukin-9 Antibodies |
| 12/04/2008 | US20080299133 Anti-Il-12 Antibody Based Vectors, Host Cells, and Methods of Production and Uses |
| 12/04/2008 | US20080299130 Methods And Compositions For The Treatment Of Ocular Neovascularization |
| 12/04/2008 | US20080299129 Antagonists to il-17a, il-17f, and il-23p19 and methods of use |
| 12/04/2008 | US20080299128 prevent immune cells from binding to other cells by contacting the immune cells and the other cells with a composition with bone marrow stromal cell antigen 2 (Bst2) antagonist; antiinflamatory agents |
| 12/04/2008 | US20080299127 Protective staphylococcus aureus vaccine based on cell wall-associated proteins |
| 12/04/2008 | US20080299126 Having high affinity and may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen-binding fragments thereof; useful for increasing muscle mass, increasing bone density, or for the treatment of various disorders in mammalian and avian species |
| 12/04/2008 | US20080299124 Novel method for the stabilization of chimeric immunoglobulin or immunoglobulin fragments and, and stabilized anti-egp-2 scfv fragment |
| 12/04/2008 | US20080299123 Treatment of chemotherapy- or radiotherapy-resistant tumors |
| 12/04/2008 | US20080299122 Modulating immune responses |
| 12/04/2008 | US20080299121 Multivalent recombinant antibodies for treating HRV infections |
| 12/04/2008 | US20080299120 Multivalent antibodies and uses therefor |
| 12/04/2008 | US20080299119 Polypeptides homologous to vegf and bmp1 |
| 12/04/2008 | US20080299116 Vascular Endothelial Cell Growth Factor Antagonists and Uses Thereof |
| 12/04/2008 | US20080299115 Antibody Variants with Faster Antigen Association Rates |
| 12/04/2008 | US20080299114 Humaneered anti-factor b antibody |
| 12/04/2008 | US20080299112 Human Polyclonal Antibodies from Genetically Engineered Animals |
| 12/04/2008 | US20080299111 Prevention, treatment and diagnosis of diseases associated with beta-amyloid formation and/or aggregation |
| 12/04/2008 | US20080299102 Novel BACE proteins, nucleic acid molecules therefor, novel crystal structure of novel BACE proteins, and methods for making and using |
| 12/04/2008 | US20080299081 Polynucleotides and Polypeptides of the IFNalpha-21 Gene |
| 12/04/2008 | US20080299039 Aprotinin Polypeptides for Transporting a Compound Across the Blood-Brain Barrier |
| 12/04/2008 | CA2693819A1 Hematopoietic cells that express mosc-1 |
| 12/04/2008 | CA2689895A1 Non-glycosylated recombinant monovalent antibodies |
| 12/04/2008 | CA2689695A1 Transgenic animals producing monovalent human antibodies and antibodies obtainable from these animals |
| 12/04/2008 | CA2689290A1 Rsv-specific binding molecules and means for producing them |
| 12/04/2008 | CA2688284A1 Streptococcus pneumoniae pilus antigens |
| 12/04/2008 | CA2688275A1 Stable igg4 antibodies |
| 12/04/2008 | CA2687937A1 Novel gpiiia gene |
| 12/04/2008 | CA2687837A1 Immunoglobulin purification |
| 12/04/2008 | CA2687586A1 Humanized and chimeric anti-trop-2 antibodies that mediate cancer cell cytotoxicity |
| 12/04/2008 | CA2687583A1 Chimeric and humanized anti-cd44 antibodies that mediate cancer cell cytotoxicity |
| 12/04/2008 | CA2687575A1 Humanized and chimeric anti-cd59 antibodies that mediate cancer cell cytotoxicity |
| 12/04/2008 | CA2687499A1 New indications for anti- il-i-beta therapy |
| 12/04/2008 | CA2687377A1 Immunoglobulin fusion proteins |
| 12/04/2008 | CA2687206A1 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 12/04/2008 | CA2683800A1 Method for manufacturing a recombinant polyclonal protein |
| 12/04/2008 | CA2683498A1 Prevention and treatment of complement-associated eye conditions |
| 12/04/2008 | CA2665885A1 Treatment and prevention of chronic asthma using antagonists of integrin .alpha.nu.beta.6 |
| 12/03/2008 | EP1998266A2 Method for identification of T-cell epitopes and use for preparing molecules with reduced immunogenicity |
| 12/03/2008 | EP1997894A2 Biosynthetic binding protein for cancer marker |
| 12/03/2008 | EP1997893A1 Compositions containing an OX-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response |
| 12/03/2008 | EP1997891A1 Generation and selection of recombinant varied binding proteins |
| 12/03/2008 | EP1997832A1 Monoclonal antibodies against Claudin-18 for treatment of cancer |
| 12/03/2008 | EP1997831A1 Chimeric vaccine antigens against the avian influenza virus |
| 12/03/2008 | EP1997830A1 RSV specific binding molecules and means for producing them |
| 12/03/2008 | EP1997514A1 High avidity polyvalent and polyspecific reagents |
| 12/03/2008 | EP1997512A2 Methods for treating TWEAK-related conditions |
| 12/03/2008 | EP1997511A1 Therapeutic agent for rheumatoid arthritis |
| 12/03/2008 | EP1996716A2 Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting |
| 12/03/2008 | EP1996701A1 Cytotoxicity mediation of cells evidencing surface expression of trop-2 |
| 12/03/2008 | EP1996700A1 Cancerous disease modifying antibody 141205-05 |
| 12/03/2008 | EP1996699A1 Cancerous disease modifying antibodies |
| 12/03/2008 | EP1996626A1 Anti-idiotypic antibody which neutralizes the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii |
| 12/03/2008 | EP1996625A1 Anti-tat226 antibodies and immunoconjugates |
| 12/03/2008 | EP1996624A1 Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and ovarian cancer |
| 12/03/2008 | EP1996623A1 Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and prostate cancer |
| 12/03/2008 | EP1996622A2 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 12/03/2008 | EP1996621A2 Antibodies |
| 12/03/2008 | EP1996620A1 Affinity regions |
| 12/03/2008 | EP1996231A2 Antibodies recognizing a highly expressed putative antigen of ca-mrsa and methods of use |
| 12/03/2008 | EP1996230A1 Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergies |
| 12/03/2008 | EP1996221A2 Methods for reducing protein aggregation |
| 12/03/2008 | EP1949109A4 Peptide sequence that promotes tumor invasion |
| 12/03/2008 | EP1328812B1 Method for quantifying phosphokinase activity on proteins |
| 12/03/2008 | EP1187632B1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 12/03/2008 | EP1121140B1 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 12/03/2008 | EP1043395B1 Novel g protein-coupled receptor proteins |
| 12/03/2008 | EP0606217B2 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 12/03/2008 | CN101317089A Detection or quantification of aggrecan and its fragments |
| 12/03/2008 | CN101316930A T-cell adhesion molecule and antibody directed against the molecule |
| 12/03/2008 | CN101316927A FcRn受体的用途 FcRn receptor usage |
| 12/03/2008 | CN101316863A Immunotherapeutic treatment for inducing the regression of atherosclerotic plaques |
| 12/03/2008 | CN101316861A IL-17A and IL-17F antagonists and methods of using the same |
| 12/03/2008 | CN101316626A Methods for reducing blood pressure |
| 12/03/2008 | CN101315378A Method and special ELISA reagent kit for detecting nitryl imidazole medicament |
| 12/03/2008 | CN101314618A Immune detection method for residual aryl-N-methyl carbamate pesticide |
| 12/03/2008 | CN101314616A Hemorrhagic bacillus coli of intestine 0157:H7 shiga toxin IIB epitope peptide and uses thereof |
| 12/03/2008 | CN100439499C Neutrokine-alpha and Neutrokine-alpha splice variant |
| 12/03/2008 | CN100439400C Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |